05/14/2024 3:03 PM | TFF Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 3:04 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 4:13 PM | INTRACOASTAL CAPITAL, LLC (Filed by) TFF Pharmaceuticals (Subject)
| Form SC 13G | |
05/08/2024 3:26 PM | CARLSON CAPITAL L P (Filed by) TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/06/2024 11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
05/01/2024 9:54 AM | TFF Pharmaceuticals (Filer)
| Form 424B4 | |
04/29/2024 11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
|
04/29/2024 6:15 AM | TFF Pharmaceuticals (Filer)
| Form S-1/A | |
04/29/2024 5:06 AM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 3:32 PM | TFF Pharmaceuticals (Filer)
| Form S-1/A | |
04/22/2024 7:49 PM | Mikhak Zamaneh (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:49 PM | COLEMAN KIRK ALLEN (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:50 PM | Roberts Brandi (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:51 PM | MILLS ROBERT S (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:52 PM | Lee Catherine Chai-zon (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:52 PM | Patane Michael A (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:53 PM | KING THOMAS BRAXTON (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:47 PM | TFF Pharmaceuticals (Issuer) Weisman Harlan F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:48 PM | ROCAMBOLI STEPHEN (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 3:24 PM | TFF Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024 3:24 PM | TFF Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024 3:19 PM | TFF Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2024 3:20 PM | TFF Pharmaceuticals (Filer)
| Form DEFA14A | |
04/18/2024 4:20 PM | TFF Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/08/2024 5:41 AM | TFF Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/28/2024 3:05 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:01 PM | TFF Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/22/2024 7:00 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
02/14/2024 5:48 PM | LYTTON LAURENCE W (Filed by) TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/19/2023 5:07 AM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
12/08/2023 3:52 PM | TFF Pharmaceuticals (Filer)
| Form S-3/A | |
12/04/2023 4:25 PM | Lee Catherine Chai-zon (Reporting) TFF Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/04/2023 4:25 PM | Patane Michael A (Reporting) TFF Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/04/2023 4:26 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 4:27 PM | Lee Catherine Chai-zon (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 4:28 PM | Patane Michael A (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 4:29 PM | ROCAMBOLI STEPHEN (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 4:30 PM | MILLS ROBERT S (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 4:31 PM | Roberts Brandi (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 4:14 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Urgent Nvidia Warning (Ad) Could Steve Job's 'Final Prophecy' Make You Rich?
Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… |
11/21/2023 3:41 PM | TFF Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/14/2023 3:06 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 3:16 PM | TFF Pharmaceuticals (Filer)
| Form PRE 14A | |
09/18/2023 4:20 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:10 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 4:27 PM | Asgard Investment Corp. II (Reporting) CARLSON CAPITAL L P (Reporting) Carlson Clint Duane (Reporting) Double Black Diamond Offshore Ltd (Reporting) TFF Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/17/2023 4:29 PM | Asgard Investment Corp. II (Reporting) CARLSON CAPITAL L P (Reporting) Carlson Clint Duane (Reporting) Double Black Diamond Offshore Ltd (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 3:43 PM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
08/15/2023 7:00 AM | Mikhak Zamaneh (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | MILLS ROBERT S (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | COLEMAN KIRK ALLEN (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | Roberts Brandi (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | ROCAMBOLI STEPHEN (Reporting) TFF Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 7:00 AM | TFF Pharmaceuticals (Issuer) Weisman Harlan F (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 5:11 AM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2023 5:02 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
06/23/2023 4:18 PM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
06/23/2023 4:15 PM | TFF Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |